Polymorphisms in the eNOS gene and the risk of coronary artery disease: Making the case for genome-wide association studies

Abstract

Get full access to this article

View all access options for this article.

References

Nobelprize.org. Alfred Noble’s Health and His Interest in Medicine. 1998. www.nobelprize.org/alfred_nobel/biographical/articles/ringertz/ (accessed 14 August 2018).

Marsh

. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol 2000; 27: 313–319.

Harrison

Thakkar

Senzaki

et al.

Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with l-n(G)-methylarginine hydrochloride 546C88. Crit Care Med 2000; 28: 1263–1268.

Guyton AC and Hall JE. Textbook of Medical Physiology, 13th ed., Philadelphia, PA: Elsevier, 2015.

Farah

Michel

LYM

Balligand

. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol 2018; 15: 292–316.

Palmer

Ashton

Moncada

. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1998; 333: 664–666.

Balligand

Feron

Dessy

. eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev 2009; 89: 481–534.

Dimmeler

Fleming

Fisslthaler

et al.

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601–605.

Bibli

Zhou

Zukunft

et al.

Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: role of PYK2. Cardiovasc Res 2017; 113: 926–937.

10.

Yeh

Duncan

Yamashita

et al.

Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin. J Biol Chem 1999; 274: 33148–33154.

11.

Briasoulis

Tousoulis

Androulakis

et al.

Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches. Recent Pat Cardiovasc Drug Discov 2012; 7: 21–32.

12.

Xuan

Tian

et al.

Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: a meta-analysis based on 4713 participants. Eur J Prev Cardiol 2016; 23: 502–510.

13.

Steidle-Kloc

Schönfelder

Müller

et al.

Does exercise training impact clock genes in patients with coronary artery disease and type 2 diabetes mellitus?

Eur J Prev Cardiol 2016; 23: 1375–1382.

14.

Ueland

Laugsand

Vatten

et al.

Extracellular matrix markers and risk of myocardial infarction: the HUNT Study in Norway. Eur J Prev Cardiol 2017; 24: 1161–1167.

15.

Li X, Lin Y and Zhang R. Associations between eNOS gene polymorphisms and the risk of coronary artery disease: a systematic review and meta-analysis of 132 case-control studies. Eur J Prev Cardiol 2019; 26: 160–170.

16.

Baudhuin

. Genetics of coronary artery disease: focus on genome-wide association studies. Am J Transl Res 2009; 1: 221–234.

17.

Erdmann J, Kessler T, Munoz Venegas L, et al. A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Cardiovasc Res 2018; 114: 1241–1257.

18.

Nikpay

Goel

Won

et al.

A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 2015; 47: 1121–1130.

19.

Kessler

Vilne

Schunkert

. The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease. EMBO Mol Med 2016; 8: 688–701.

20.

Deloukas

Kanoni

et al.

CARDIoGRAMplusC4D Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013; 45: 25–33.

21.

Erdmann

Stark

Esslinger

et al.

Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature 2013; 504: 432–436.